avacopan

Flash FDA approval sends ChemoCentryx spiralling upwards
Pharmaforum
Sun, 10/10/21 - 09:48 pm
ChemoCentryx
FDA
avacopan
Tavneos
ANCA-positive vasculitis
Adcomm splits slightly in favor of FDA approving ChemoCentryx’s rare disease drug
Endpoints
Thu, 05/6/21 - 11:06 pm
FDA
advisory panels
ChemoCentryx
avacopan
ANCA-positive vasculitis
Chemocentryx takes a leap of faith with avacopan
EP Vantage
Thu, 10/29/20 - 12:13 pm
ChemoCentryx
avacopan
clinical trials
hidradenitis suppurativa
ChemoCentryx Drug Hits Co-Primary Endpoints in Phase III Vasculitis Trial
BioSpace
Tue, 11/26/19 - 11:37 pm
ChemoCentryx
Vifor Fresenius Medical Care Renal Pharma
avacopan
ANCA-positive vasculitis
clinical trials